Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extracorporeal CO2 Removal May Improve Renal Function of Patients with Acute Respiratory Distress Syndrome and Acute Kidney Injury: An Open-Label, Interventional Clinical Trial.
Fanelli V, Cantaluppi V, Alessandri F, Costamagna A, Cappello P, Brazzi L, Pugliese F, Biancone L, Terragni P, Ranieri VM. Fanelli V, et al. Among authors: alessandri f. Am J Respir Crit Care Med. 2018 Sep 1;198(5):687-690. doi: 10.1164/rccm.201712-2575LE. Am J Respir Crit Care Med. 2018. PMID: 29708394 No abstract available.
Prone Positioning for ARDS: still misunderstood and misused.
Pugliese F, Babetto C, Alessandri F, Ranieri VM. Pugliese F, et al. Among authors: alessandri f. J Thorac Dis. 2018 Jun;10(Suppl 17):S2079-S2082. doi: 10.21037/jtd.2018.04.157. J Thorac Dis. 2018. PMID: 30023124 Free PMC article. No abstract available.
Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study.
Combes A, Fanelli V, Pham T, Ranieri VM; European Society of Intensive Care Medicine Trials Group and the “Strategy of Ultra-Protective lung ventilation with Extracorporeal CO2 Removal for New-Onset moderate to severe ARDS” (SUPERNOVA) investigators. Combes A, et al. Intensive Care Med. 2019 May;45(5):592-600. doi: 10.1007/s00134-019-05567-4. Epub 2019 Feb 21. Intensive Care Med. 2019. PMID: 30790030 Free article.
Determinants of the effect of extracorporeal carbon dioxide removal in the SUPERNOVA trial: implications for trial design.
Goligher EC, Combes A, Brodie D, Ferguson ND, Pesenti AM, Ranieri VM, Slutsky AS; SUPERNOVA investigators (European Society of Intensive Care Medicine trials group)  and for the International ECMO Network (ECMONet). Goligher EC, et al. Intensive Care Med. 2019 Sep;45(9):1219-1230. doi: 10.1007/s00134-019-05708-9. Epub 2019 Aug 20. Intensive Care Med. 2019. PMID: 31432216
Is teicoplanin a complementary treatment option for COVID-19? The question remains.
Ceccarelli G, Alessandri F, d'Ettorre G, Borrazzo C, Spagnolello O, Oliva A, Ruberto F, Mastroianni CM, Pugliese F, Venditti M; Intensive Care COVID-19 Study Group of Sapienza University. Ceccarelli G, et al. Among authors: alessandri f. Int J Antimicrob Agents. 2020 Aug;56(2):106029. doi: 10.1016/j.ijantimicag.2020.106029. Epub 2020 May 23. Int J Antimicrob Agents. 2020. PMID: 32454071 Free PMC article. No abstract available.
Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19.
Violi F, Ceccarelli G, Cangemi R, Alessandri F, D'Ettorre G, Oliva A, Pastori D, Loffredo L, Pignatelli P, Ruberto F, Venditti M, Pugliese F, Mastroianni CM. Violi F, et al. Among authors: alessandri f. Circ Res. 2020 Jul 17;127(3):400-401. doi: 10.1161/CIRCRESAHA.120.317173. Epub 2020 Jun 8. Circ Res. 2020. PMID: 32508261 No abstract available.
141 results